Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. De la Cruz
Pcn17 - Indirect Treatment Comparisons of Nivolumab Versus Regorafenib, Cabozantinib and Best Supportive Care After Treatment With Sorafenib for Hepatocellular Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity
Internal Medicine
Internal Medicine
Medicine
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib and Best Supportive Care in Previously Treated Renal Cell Carcinoma: A Systematic Review and Economic Evaluation
Health Technology Assessment
Medicine
Health Policy
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis
Journal of Hepatology
Hepatology
Multiple Comparisons With the Best Treatment
Journal of the American Statistical Association
Uncertainty
Statistics
Probability
Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?
Hepatology
Medicine
Hepatology
Radioembolisation With Yttrium‒90 Microspheres Versus Sorafenib for Treatment of Advanced Hepatocellular Carcinoma (SARAH): Study Protocol for a Randomised Controlled Trial
Trials
Medicine
Pharmacology
Pcn151 - Cost-Effectiveness Analysis of Regorafenib in the Treatment of Patients With Hepatocelullar Carcinoma Previously Treated With Sorafenib in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
